Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.

Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.

Show other versions (1)

<h4>Objectives</h4>To identify and describe the profile of potential transthyretin cardiac amyloidosis (ATTR-CM) cases in the Brazilian public health system (SUS), using a predictive machine learning (ML) model.<h4>Methods</h4>This was a retrospective descriptive database stu...

Full description

Bibliographic Details
Main Authors:	Isabella Zuppo Laper, Cecilia Camacho-Hubner, Rafaela Vansan Ferreira, Claudenice Leite Bertoli de Souza, Marcus Vinicius Simões, Fabio Fernandes, Edileide de Barros Correia, Ariane de Jesus Lopes de Abreu, Guilherme Silva Julian
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0278738&type=printable

Similar Items

Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model
by: Isabella Zuppo Laper, et al.
Published: (2024-01-01)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
by: Alexandre Marins Rocha, et al.

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
by: Paolo Morfino, et al.
Published: (2023-04-01)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
by: Tomoya Nakano, et al.
Published: (2022-05-01)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
by: Marianna Fontana, et al.
Published: (2023-11-01)

Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
by: Eirik Aaseth, et al.
Published: (2024-04-01)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
by: Mario Nuvolone, et al.
Published: (2022-12-01)

Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
by: Katharina Knoll, et al.
Published: (2023-07-01)

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
by: Rosa Lauppe, et al.
Published: (2022-06-01)

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
by: Benjamin Li, et al.
Published: (2020-06-01)

Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
by: Sergey N. Tereshchenko, et al.
Published: (2022-05-01)

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy
by: Kent Y. Feng, MD, et al.
Published: (2019-12-01)

Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
by: Carsten Tschöpe, et al.
Published: (2022-04-01)

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01)

Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design
by: Valeriia V. Guselnikova, et al.
Published: (2022-05-01)

False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy
by: Cristina Chimenti, et al.
Published: (2021-08-01)

Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy
by: Yu Hashimoto, et al.
Published: (2023-03-01)

Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials
by: Daniela Tomasoni, et al.
Published: (2023-05-01)

Health‐related quality of life among transthyretin amyloid cardiomyopathy patients
by: Per Eldhagen, et al.
Published: (2023-06-01)

Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
by: Rosa Lauppe, et al.
Published: (2022-08-01)

Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
by: Shan He, et al.
Published: (2019-11-01)

Transthyretin Gene Variants and Associated Phenotypes in Danish Patients with Amyloid Cardiomyopathy
by: Torsten B. Rasmussen, et al.
Published: (2022-01-01)

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
by: Mami Morioka, et al.
Published: (2022-06-01)

Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study
by: Yüksel Çavuşoğlu, et al.
Published: (2024-01-01)

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
by: Ana-Maria Merino-Merino, et al.
Published: (2023-12-01)

Musculoskeletal co‐morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review
by: Francesc Formiga, et al.
Published: (2024-04-01)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Toshihiro Yamada, et al.
Published: (2020-10-01)

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT
by: Jose Nativi‐Nicolau, et al.
Published: (2021-10-01)

Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
by: Ian Winburn, et al.
Published: (2019-08-01)

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
by: Sandra Arvidsson, et al.
Published: (2015-01-01)

Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records
by: Ana Moya, et al.
Published: (2023-12-01)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
by: Seiji Takashio, et al.
Published: (2023-08-01)

NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
by: Hiroki Usuku, et al.
Published: (2023-08-01)

Stumbling across transthyretin amyloid cardiomyopathy during diagnostic work-up for stomach cancer
by: Hyun-Ki Lee, et al.
Published: (2023-03-01)

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
by: Fumi Oike, et al.
Published: (2021-12-01)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
by: Fumi Oike, et al.
Published: (2022-06-01)

Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases
by: Thibaud Damy, et al.
Published: (2023-11-01)

Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden
by: Frida Hjalte, et al.
Published: (2023-12-01)

Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation
by: Stephan Dobner, et al.
Published: (2023-08-01)